Zimmer Biomet
993 hedge funds and large institutions have $23.9B invested in Zimmer Biomet in 2023 Q1 according to their latest regulatory filings, with 98 funds opening new positions, 328 increasing their positions, 341 reducing their positions, and 63 closing their positions.
151% more call options, than puts
Call options by funds: $50.1M | Put options by funds: $19.9M
56% more first-time investments, than exits
New positions opened: 98 | Existing positions closed: 63
2% more funds holding
Funds holding: 977 → 993 (+16)
1% more capital invested
Capital invested by funds: $23.6B → $23.9B (+$271M)
0.93% less ownership
Funds ownership: 88.88% → 87.95% (-0.93%)
4% less repeat investments, than reductions
Existing positions increased: 328 | Existing positions reduced: 341
31% less funds holding in top 10
Funds holding in top 10: 13 → 9 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$265M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$224M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$194M |
| 4 |
NI
Nuance Investments
Kansas City,
Missouri
|
+$130M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$38.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$637M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$292M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$145M |
| 4 |
BlackRock
New York
|
-$100M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$96.4M |
ZBH Hedge Fund Activity: Q1 2023 in Review
993 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q1 2023, worth a combined $23.9B — up 1.1% from $23.6B a quarter earlier.
Buyers outnumbered sellers: 98 funds opened new ZBH positions and 63 closed out — a net gain of 35 holders — while 328 added to existing stakes and 341 trimmed.
The largest buyer was Millennium Management, adding an estimated $265M. The largest seller was Capital International Investors, exiting entirely with an estimated $637M sold.
- 993 institutional investors held Zimmer Biomet (ZBH) as of Q1 2023, up from 977 in Q4 2022.
- Funds reported $23.9B of Zimmer Biomet stock for Q1 2023, up 1.1% quarter-over-quarter.
- 98 funds opened new Zimmer Biomet positions in Q1 2023 and 63 closed out, a net change of +35 holders.
- The largest Zimmer Biomet buyer in Q1 2023 was Millennium Management, an estimated $265M added.
- The largest Zimmer Biomet seller in Q1 2023 was Capital International Investors, an estimated $637M sold.
Based on aggregated 13F filings for Q1 2023.